Summary GlobalData’s new report, Canada Ostomy Procedures Outlook to 2024, provides key procedures data on the Canada Ostomy Procedures. The report provides procedure volumes within market segments - Conventional Colostomy Procedures, Conventional Ileostomy Procedures and Conventional Urostomy Procedures.
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.
Scope - Canada Ostomy Procedures volumes by segments - Conventional Colostomy Procedures, Conventional Ileostomy Procedures and Conventional Urostomy Procedures. - Projections for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
Reasons to buy - Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future. - Develop market-entry and market expansion strategies.
Our reports have been used by over 10K customers, including:
The global medical engineered materials market size is projected to reach USD 29.1 billion by 2025 from USD 15.8 billion in 2020, at a CAGR of 13.0%. This growth is attributed to the increasing healthcare expenses in emerging economies, and rising geriatric population increasing need of advanced medical technologies and devices. Also, innovations...
The ostomy care market projected to grow at a CAGR of 4.4% over the forecast period of 2020-2025. The ostomy care market is projected to reach USD 3.5 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 4.4% during the forecast period. Globally, the population of individuals aged 60 years and above is expected to increase from 962...
406 pages •
By Global Industry Analysts
• Feb 2019
This report analyzes the worldwide markets for Incontinence and Ostomy Care Products in US$ Thousand by the following Product Segments: Incontinence Products (Disposable Adult Diapers, Disposable Adult Shields, Disposable Under Pads, Drainage Bags, Incontinence Clamps, Incontinence Cleaners, Deodorizers & Urinals), and Ostomy Products...
North America Surgical Generators Market Outlook to 2023 Summary GlobalData’s new report, "North America Surgical Generators Market Outlook to 2023", provides key market data on the North America Surgical Generators market. The report provides value, in millions of US dollars, volume (in units) and and average prices...
Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: Datamonitors' Meridian...
Summary Aerocrine AB (Aerocrine), a subsidiary of Circassia Pharmaceuticals Plc, is a medical products company. It markets and sells medical devices and tests. The company offers its products for diagnosis, treatment and monitoring of patients suffering from inflammation of airways. The company offers nitric oxide (NO) monitoring...
Summary Obagi Medical Products Inc (Obagi), a subsidiary of Valeant Pharmaceuticals International Inc is a drug company that manufactures, sells, and markets skin care systems.The company provides products that include targeted solutions, tretinoin products, transformation systems, skin recovery, in-office procedures, essential...
Summary Celleration, Inc. (Celleration), a subsidiary of Alliqua BioMedical, Inc. is a medical device company that commercializes and develops therapeutic ultrasound platform. The company offers medical products for wound care markets. Its MIST therapy is a noncontact, painless, and low frequency ultrasound delivered through...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.